Skip to main content

Table 3 Comparison of baseline and yearly change of health status between subjects with or without at least one acute exacerbation during the follow up, among those with airflow obstruction

From: Health status deterioration in subjects with mild to moderate airflow obstruction, a six years observational study

 

Exacerbation(s) during follow up

No exacerbation during follow up

p

 

(n = 25)

(n = 36)

 

Baseline

 SF36 PCS (sum score)

76.4 [65.1–82]

76 [64.6–81.3]

0.92

 SF36 MCS (sum score)

79.5 [72.5–84.3]

80.1 [74.0–85.8]

0.79

 EQ-5D index (score)

0.76 [0.74–1]

0.77 [0.76–1.00]

0.70

 EQ-5D VAS (score)

75 [70–80]

80 [70–85]

0.48

 CCQ (total score)

1.2 [0.3–1.5]

0.70 [0.40–1.00]

0.22

 CAT (score)a

10.5 [6–17.5]

8 [5–13]

0.11

Yearly change

 SF36 PCS (sum score)

−1.51 (0.47)

−0.50 (0.53)

0.16

 SF36 MCS (sum score)

−1.22 (0.54)

0.03 (0.45)

0.16

 EQ-5D index (score)

−0.022 (0.010)

−0.015 (0.012)

0.66

 EQ-5D VAS (score)

−0.82 (0.47)

− 0.40 (0.35)

0.48

 CCQ (total score)

0.068 (0.025)

0.042 (0.028)

0.63

 CAT (score)

0.91 (0.21)

−0.26 (0.25)

< 0.01

  1. Data are expressed as median [interquartile range] or average (SE). Baseline data were compared with a Mann–Whitney test, yearly change with a mixed model. SF36 = Short form 36 health survey, PCS = physical component summary, MCS = mental component summary, EQ-5D = Generic EuroQol 5 dimensions, VAS = visual analog scale, CCQ = Clinical COPD Questionnaire, CAT = COPD assessment test (a= data from the third year visit). Missing values: Had acute exacerbation(s) – EQ-5D index and CAT n = 1, CCQ n = 3, in both baseline and yearly change. Did not have acute exacerbation – Baseline: SF36 n = 1, EQ-5D index and CCQ n = 3, EQ-5D VAS n = 2, CAT n = 13. Yearly change: SF36 and EQ-5D index n = 7, EQ-5D VAS n = 8, CCQ n = 9, CAT n = 12